Cite
HARVARD Citation
Abbass, S. et al. (2021). Efficacy and safety of sofosbuvir plus daclatasvir or ravidasvir in patients with COVID‐19: A randomized controlled trial. Journal of medical virology. 93 (12), pp. 6750-6759. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Abbass, S. et al. (2021). Efficacy and safety of sofosbuvir plus daclatasvir or ravidasvir in patients with COVID‐19: A randomized controlled trial. Journal of medical virology. 93 (12), pp. 6750-6759. [Online].